Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-03

Clinical Trial Update: Efficacy of Prazosin in Preventing Post-traumatic Stress Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether prazosin can prevent the development of post-traumatic stress disorder in individuals with acute stress disorder; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Stress Disorder | Phase 2 | Status: COMPLETED